Published 1 month ago • loading... • Updated 1 month ago

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

Summary by Businessfortnight

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS’ LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism. DUBLIN, Calif. and JENA, Germany, Jan. 13, 2025 /PRNewswire/ — ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology simultaneous approval for all three major indicati…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

8 Articles

All

Left

Center

Right

San Diego Business Journal

Epirium Bio Nets FDA Approval of IND - San Diego Business Journal

SAN DIEGO – Biopharmaceutical company Epirium Bio, Inc., received approval last month from federal regulators to begin clinical trials for its orally administered candidate to treat sarcopenia, the age-related progressive loss of muscle mass. Alex CasdinCEOEpirium Bio, Inc. The U.S. Food and Drug Administration cleared Epirium’s application for Investigational New Drug (IND) status for MF-300, […]

1 month ago

Read Full Article

Med-Tech Innovation | Latest news for the medical device industry

ZEISS MEL 90 excimer laser receives U.S. FDA approval

ZEISS Medical Technology has announced that its MEL 90 device has received approval from the FDA, giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia and mixed astigmatism.

1 month ago

Read Full Article

optometrytimes.com

FDA approves Zeiss MEL 90 excimer laser

With this addition, Zeiss completes the Corneal Refractive Workflow, which already includes Visumax 800 and SMILE pro.

1 month ago

Read Full Article

Medical Device Network

FDA approves Zeiss Medical Technology’s MEL 90 excimer laser

The US Food and Drug Administration (FDA) has approved Zeiss Medical Technology’s MEL 90 excimer laser technology.The post FDA approves Zeiss Medical Technology’s MEL 90 excimer laser appeared first on Medical Device Network.

1 month ago

Read Full Article

Businessfortnight

Latest News ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow - Businessfortnight

1 month ago

Read Full Article

Eyewire+

FDA Approves Zeiss MEL 90 Excimer Laser

Zeiss has received FDA approval for the MEL 90, giving the excimer laser technology simultaneous approval for all three major indications: myopia, hyperopia, and mixed astigmatism. The Zeiss MEL 90 fully integrates into the company's Corneal Refractive Workflow, and is designed to offer US surgeons a fast, reliable, and streamlined surgery experience, complementing the VISUMAX 800 with SMILE pro from Zeiss to help further broaden a surgeon’s ref…

1 month ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year